Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.

Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.
复制标题

内皮糖蛋白启动子高甲基化鉴定了人类原发性食管癌的场缺陷

DOI:
10.1002/cncr.28276
复制
发表时间:
2013-10-15
期刊:
影响因子:
6.2
通讯作者:
Meltzer, Stephen J.
Meltzer, Stephen J.
中科院分区:
医学1区
文献类型:
--
作者:
Jin, Zhe;Zhao, Zhenfu;Cheng, Yulan;Dong, Ming;Zhang, Xiaojing;Wang, Liang;Fan, Xinmin;Feng, Xianling;Mori, Yuriko;Meltzer, Stephen J.

文献摘要

参考文献

相似文献

内元(ENG)是一种180 kDa的跨膜糖蛋白,它是转化的生长因子-β受体复合物的成分,据报道,在几种人类癌症中,我们使用了2600个人类的Enderigation pristeration pristeration pristeration proferation,伊尔斯,显然是区别于食管鳞状细胞癌(ESCC)和食管腺癌(EAC)正常食管(n)(p <0.01),ESCC的归一化甲基化值显着高于N(p <0.01)或EAC频率为46.2%。肿瘤进展,至13.3% Barrett的Metaplasia(BE),ESCC患者的N型ENC患者(平均值= 0.0186)的ENK EAC中的25%和26.9%的EAC EAC高度高。我们的Eng mRNA表达结论是,ENG的启动子过度甲基化是人ESCC中经常的组织特异性事件,并且在ESCC的早期检测中表现出具有承诺的生物标志物潜力的田间缺陷。
Endoglin (ENG) is a 180-kDa transmembrane glycoprotein that functions as a component of the transforming growth factor-β receptor complex. Recently, ENG promoter hypermethylation was reported in several human cancers. We examined ENG promoter hypermethylation using real-time quantitative methylation-specific PCR in 260 human esophageal tissues. ENG hypermethylation showed highly discriminative receiver-operator characteristic curve profiles, clearly distinguishing esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) from normal esophagus (N) (p<0.01). Interestingly, ENG normalized methylation values were significantly higher in ESCC than in N (p<0.01) or EAC (p<0.01). ENG hypermethylation frequency was 46.2% in ESCC and 11.9% in N, but increased early and sequentially during EAC-associated neoplastic progression, to 13.3% in Barrett’s metaplasia (BE), 25% in dysplastic BE (D), and 26.9% in frank EAC. ENG hypermethylation was significantly higher in N from ESCC patients (mean = 0.0186) than in N from EAC patients (mean = 0.0117; p < 0.05). Treatment of KYSE220 ESCC cells with the demethylating agent, 5-aza-2′-deoxycytidine, reversed ENG methylation and reactivated ENG mRNA expression. We conclude that promoter hypermethylation of ENG is a frequent, tissue-specific event in human ESCC and exhibits a field defect with promising biomarker potential for the early detection of ESCC. In addition, ENG hypermethylation occurs in a subset of human EAC, and early during BE-associated esophageal neoplastic progression.
DOI: 10.1136/gut.2005.089813
发表时间: 2007-01-01
期刊: GUT
影响因子: 24.5
作者:
Ishii, T.;Murakami, J.;Matsubara, N.
通讯作者: Matsubara, N.
DOI: 10.1002/pros.10083
发表时间: 2002-06-01
期刊: PROSTATE
影响因子: 2.8
作者:
Wikström, P;Lissbrandt, IF;Bergh, A
通讯作者: Bergh, A
DOI: 10.1038/sj.onc.1210461
发表时间: 2007-09-20
期刊: ONCOGENE
影响因子: 8
作者:
Jin, Z.;Mori, Y.;Meltzer, S. J.
通讯作者: Meltzer, S. J.
DOI: 10.1038/sj.onc.1208598
发表时间: 2005-06-09
期刊: ONCOGENE
影响因子: 8
作者:
Schulmann, K;Sterian, A;Meltzer, SJ
通讯作者: Meltzer, SJ
DOI: 10.1053/j.gastro.2006.06.006
发表时间: 2006-09-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Mori, Yuriko;Cai, Kun;Meltzer, Stephen J.
通讯作者: Meltzer, Stephen J.